| CAS登錄號(hào) | 中文名 | 英文名 | 分子結(jié)構(gòu)式 | 分子式 | 詳情 | 供應(yīng)商 |
| 36322-90-4 | 吡羅昔康; 2-甲基-4-羥基-N-(2-吡啶基)-2H-1,2-苯并噻嗪-3-甲酰胺-1,1-二氧化物 | Piroxicam; 4-Hydroxy-2-methyl-N-2-pyridinyl-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide |  | C15H13N3O4S | 詳情 | 供應(yīng)商 |
| 51035-40-6 | 2-(4-羥基苯基)吡啶 | 2-(4-Hydroxypenyl)pyridine; Phenol,4-(2-pyridinyl)-; 4-(2-Pyridinyl)phenol; 4-(2-Pyridyl)phenol; p-(2-Pyridyl)phenol; |  | C11H9NO | 詳情 | 供應(yīng)商 |
| 70797-11-4 | 頭孢匹胺; 頭孢匹胺酸; 7-[2-[(4-羥基-6-甲基吡啶-3-羰基)-氨基]-2-(4-羥基苯基)-乙酰氨基]-3-(1-甲基-1H-四? | Cefpiramide acid; 7-[2-[(4-hydroxy-6-methylpyridine-3-carbonyl)-amino]-2-(4-hydroxy phenyl)-acetylamin]-3-(1-methyl-1H-tetrazole-5-thiomethyl)-8-keto-5-thiox-1-azole[4.2.0]octadiene-2-carboxylic acid |  | C25H24N8O7S2 | 詳情 | 供應(yīng)商 |
| 74849-93-7 | 頭孢匹胺鈉; (6R,7R)-7-[[(2R)-2-(4-羥基苯基)-2-[(6-甲基-4-氧代-1H-吡啶-3-甲酰)氨基]乙酰]氨基]-3-[(1-甲 | Cefpiramide sodium; Sodium (6R,7R)-7-[[(2R)-2-(4-hydroxyphenyl)-2-[(6-methyl-4-oxo-1H-pyridine-3-carbonyl)amino]acetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate |  | C25H23N8NaO7S2 | 詳情 | 供應(yīng)商 |
| 82211-24-3 | 抗倒胺; N-[4-氯-2-(羥基芐基)苯基]吡啶-4-甲酰胺 | Inabenfide; N-[4-Chloro-2-(hydroxy-phenylmethyl)phenyl]pyridine-4-carboxamide |  | C19H15ClN2O2 | 詳情 | 供應(yīng)商 |
| 92340-57-3 | 5-羥基奧美拉唑; [4-甲氧基-6-[(6-甲氧基-1H-苯并咪唑-2-基)亞磺酰甲基]-5-甲基吡啶-3-基]甲醇 | 5'-Hydroxyomeprazole; [4-Methoxy-6-[(6-methoxy-1H-benzimidazol-2-yl)sulfinylmethyl]-5-methylpyridin-3-yl]methanol |  | C17H19N3O4S | 詳情 | 供應(yīng)商 |
| 117976-91-7 | 去甲基雷貝拉唑硫醚; 2-{[4-(3-羥基丙氧基)-3-甲基吡啶-2-基]甲硫基}-1H-苯并咪唑 | Desmethyl rabeprazole thioether; 2-[[[4-(3-Hydroxypropoxy)-3-methyl-2-pyridyl]methyl]thio]-1H-benzimidazole; 3-[[2-[(1H-Benzimidazol-2-ylthio)methyl]-3-methyl-4-pyridinyl]oxy]-1-propanol |  | C17H19N3O2S | 詳情 | 供應(yīng)商 |
| 126268-81-3 | (-)-(S)-N-(5-氨基-2-甲基-3-苯基-l,2-二氫吡啶并[3,4-b]吡嗪-7-基)氨基甲酸乙酯2-羥基乙基磺酸鹽 | Mivobulin isethionate; Ethyl N-[(9S)-5-amino-9-methyl-8-phenyl-4,7,10-triazabicyclo[4.4.0] deca-1,3,5,7-tetraen-3-yl]carbamate 2-hydroxyethanesulfonic acid salt |  | C19H25N5O6S | 詳情 | 供應(yīng)商 |
| 143201-11-0 | 西立伐他汀鈉; (+)-(3R,5S,6E)-7-[4-(4-氟苯基)-2,6-二異丙基-5-甲氧甲基-吡啶-3-基]-3,5-二羥基-6-庚烯酸單 | Cerivastatin sodium; Sodium 7-[4-(4-fluorophenyl)-5-(methoxymethyl)-2,6-dipropan-2-yl-pyrid in-3-yl]-3,5-dihydroxy-hept-6-enoate |  | C26H33FNNaO5 | 詳情 | 供應(yīng)商 |
| 144598-75-4 | 帕潘立酮; 6,7,8,9-四氫-3-(2-(4-(6-氟-1,2-苯并異惡唑-3-基)-1-哌啶基)乙基)-9-羥基-2-甲基-4H-吡啶并[2,1- | Paliperidone; 9-Hydroxyrisperidone; 6,7,8,9-Tetrahydro-3-(2-(4-(6-fluro-1,2-benzisoxazol-3-yl)-1-piperidinyl)ethyl)-9-hydroxy-2-methyl-4H-pyrido[2,1-a]pyrimidin-4-one |  | C23H27FN4O3 | 詳情 | 供應(yīng)商 |
| 174484-41-4 | 替拉那韋; N-[3-[(1R)-1-[(6R)-2-羥基-4-氧代-6-苯乙基-6-丙基-5H-吡喃-3-基]丙基]苯基]-5-(三氟甲基)吡啶-2 | Tipranavir; N-[3-[(1R)-1-[(6R)-2-Hydroxy-4-oxo-6-phenethyl-6-propyl-5H-pyran-3-yl]propyl]phenyl]-5-(trifluoromethyl)pyridine-2-sulfonamide |  | C31H33F3N2O5S | 詳情 | 供應(yīng)商 |
| 192329-42-3 | 普馬司他; (S)-2-[(羥基氨基)甲基]-5,6-二甲基-4-(4-吡啶-4-基氧苯基)磺酰基嗎啉-3-硫酮 | Prinomastat; (S)-2-[(Hydroxyamino)methyl]-5,6-dimethyl-4-(4-pyridin-4-yloxyphenyl)sulfonylmorpholine-3-thione |  | C18H21N3O5S2 | 詳情 | 供應(yīng)商 |
| 252260-02-9 | 潑斯唑來; (5R)-3-[4-[1-[(2S)-2,3-二羥基-1-氧代丙基]-1,2,3,6-四氫-4-吡啶基]-3,5-二氟苯基]-5-[(3-異惡唑 | Posizolid; (5R)-3-[4-[1-[(2S)-2,3-Dihydroxy-1-oxopropyl]-1,2,3,6-tetrahydro-4-pyridinyl]-3,5-difluorophenyl]-5-[(3-isoxazolyloxy)methyl]-2-oxazolidinone |  | C21H21F2N3O7 | 詳情 | 供應(yīng)商 |
| 51249-07-1 | 1-(2-乙基己基)-1,2-二氫-6-羥基-4-甲基-5-[(2-硝基苯基)偶氮]-2-氧代-3-吡啶腈 | 1-(2-ethylhexyl)-1,2-dihydro-6-hydroxy-4-methyl-5-[(2-nitrophenyl) azo]-2-oxo-3-Pyridinecarbonitrile; 1-(2-ethylhexyl)-1,2-dihydro-6-hydroxy-4-methyl-5-[(2-nitrophenyl)azo]-2-oxo-3-pyridinecarbonitril |  | C21H25N5O4 | 詳情 | 供應(yīng)商 |
| 75511-91-0 | 1-丁基-5-[(2-氯-4-硝基苯基)偶氮]-1,2-二氫-6-羥基-4-甲基-2-氧代-3-吡啶腈 | 1-butyl-5-[(2-chloro-4-nitrophenyl)azo]-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-3-Pyridinecarbonitrile |  | C17H16ClN5O4 | 詳情 | 供應(yīng)商 |
| 83784-23-0 | 1-丁基-5-[(4-氯-2-硝基苯基)偶氮基]-1,6-二氫-2-羥基-4-甲基-6-氧代-3-吡啶甲腈; 5-[(4-氯-2-硝基苯基)偶氮 | 3-Pyridinecarbonitrile, 1-butyl-5-[(4-chloro-2-nitrophenyl)azo]-1,6-dihydro-2-hydroxy-4-methyl-6-oxo; 3-Pyridinecarbonitrile,1-butyl-5-[(4-chloro-2-nitrophenyl)azo]-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-,mixture with 5-[(4-chloro-2-nitrophenyl)azo]-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-1-propyl-3-pyridinecarbonitrile |  | C17H16ClN5O4 | 詳情 | 供應(yīng)商 |
| 69808-32-8 | 1-丁基-5-[(4-氯苯基)偶氮]-1,2-二氫-6-羥基-4-甲基-2-氧代-3-吡啶腈 | 1-butyl-5-[(4-chlorophenyl) azo]-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-3-Pyridinecarbonitrile; 1-Butyl-5-[(4-chlorophenyl)azo]-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-3-pyridinecarbonitrile |  | C17H17ClN4O2 | 詳情 | 供應(yīng)商 |
| 80546-45-8 | 3-[(2-羥基-1-萘)偶氮]-1-苯基(甲基)吡啶翁的氯化物 | Pyrldinium, 3-[(2-hydroxy-1-naphthalenyl)azo]-1-pheny(Methyl)-Chlorlde; Pyrldinium,3-[(2-hydroxy-1-naphthalenyl)azo]-1-pheny(Methyl)-Chlorlde | 無 | 詳情 | 供應(yīng)商 | |
| 95027-07-9 | 3-[[4-[[5-氰基-6-[(2-羥基乙基)氨基]-4-甲基-2-[[2-(4-磺基苯基)乙基]氨基]-3-吡啶基]偶氮]-2,5-二甲基苯? | Benzenesulfonic acid, 3-[[4-[[5-cyano-6-[(2-hydroxyethyl)amino]-4-methyl-2-[[2-(4-sulfophenyl)ethyl] | 無 | 詳情 | 供應(yīng)商 | |
| 55290-62-5 | 4-[(1-丁基-5-氰基-1,6-二氫-2-羥基-4-甲基-6-氧代-3-吡啶基)偶氮]-N-(2-乙基己基)-苯磺酰胺 | 4-[(1-butyl-5-cyano-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridinyl)azo]-N-(2-ethylhexyl)-Benzenesu; 1-Butyl-5-[[4-[[(2-ethylhexyl)amino]sulfonyl]phenyl]azo]-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-3-pyridinecarbonitrile 4-[(1-butyl-5-cyano-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-3-benzenesulfonamid |  | C25H35N5O4S | 詳情 | 供應(yīng)商 |